US 12,220,480 B2
Topical skin care formulations comprising plant extracts
Tiffany Florence, Dallas, TX (US); David Gan, Southlake, TX (US); and Michelle Hines, Hickory Creek, TX (US)
Assigned to MARY KAY INC., Addison, TX (US)
Filed by MARY KAY INC., Addison, TX (US)
Filed on Jun. 9, 2022, as Appl. No. 17/836,597.
Application 17/836,597 is a continuation of application No. 16/229,865, filed on Dec. 21, 2018, granted, now 11,389,391.
Application 16/229,865 is a continuation of application No. 15/596,966, filed on May 16, 2017, granted, now 10,195,137, issued on Feb. 5, 2019.
Application 15/596,966 is a continuation of application No. 15/283,684, filed on Oct. 3, 2016, granted, now 9,668,963, issued on Jun. 6, 2017.
Application 15/283,684 is a continuation of application No. 15/091,710, filed on Apr. 6, 2016, granted, now 9,463,154, issued on Oct. 11, 2016.
Application 15/091,710 is a continuation of application No. 14/660,403, filed on Mar. 17, 2015, granted, now 9,333,167, issued on May 10, 2016.
Application 14/660,403 is a continuation of application No. 14/072,426, filed on Nov. 5, 2013, granted, now 9,023,325, issued on May 5, 2015.
Application 14/072,426 is a continuation of application No. 13/888,005, filed on May 6, 2013, granted, now 8,609,072, issued on Dec. 17, 2013.
Application 13/888,005 is a continuation of application No. 13/440,798, filed on Apr. 5, 2012, granted, now 8,454,943, issued on Jun. 4, 2013.
Claims priority of provisional application 61/472,461, filed on Apr. 6, 2011.
Prior Publication US 2022/0296496 A1, Sep. 22, 2022
Int. Cl. A61K 8/9767 (2017.01); A61K 8/02 (2006.01); A61K 8/06 (2006.01); A61K 8/34 (2006.01); A61K 8/365 (2006.01); A61K 8/44 (2006.01); A61K 8/9778 (2017.01); A61K 8/9789 (2017.01); A61K 8/9794 (2017.01); A61K 36/185 (2006.01); A61K 36/28 (2006.01); A61Q 17/04 (2006.01); A61Q 19/00 (2006.01); A61Q 19/02 (2006.01); A61Q 19/08 (2006.01); A61Q 19/10 (2006.01)
CPC A61K 8/9767 (2017.08) [A61K 8/0212 (2013.01); A61K 8/06 (2013.01); A61K 8/062 (2013.01); A61K 8/34 (2013.01); A61K 8/345 (2013.01); A61K 8/365 (2013.01); A61K 8/44 (2013.01); A61K 8/9778 (2017.08); A61K 8/9789 (2017.08); A61K 8/9794 (2017.08); A61K 36/185 (2013.01); A61K 36/28 (2013.01); A61Q 17/04 (2013.01); A61Q 19/00 (2013.01); A61Q 19/02 (2013.01); A61Q 19/08 (2013.01); A61Q 19/10 (2013.01); A61K 2800/48 (2013.01); A61K 2800/524 (2013.01); A61K 2800/782 (2013.01)] 19 Claims
 
1. A method of reducing inflammation in skin, the method comprising topically applying to inflamed skin a composition comprising 0.0001% to 5% by weight of an aqueous, alcoholic, or aqueous-alcoholic extract from Ipomoea batatas, wherein inflammation is decreased in the inflamed skin.